Results 221 to 230 of about 1,017,222 (288)
ABSTRACT Objective To (1) validate GAD65‐ELISA detection and quantification for type 1 diabetes mellitus and autoimmune neurological diagnoses, (2) correlate ELISA results (reference range < 5 IU/mL) with established radioimmunoprecipitation assay (RIA; ≤ 0.02 nmol/L), and (3) define ELISA clinical utility and pitfalls.
Andrew McKeon +11 more
wiley +1 more source
ABSTRACT Objective High‐resolution MRI enables detailed assessment of intracranial vessel wall pathology in moyamoya vasculopathy. We aimed to classify adult moyamoya vasculopathy etiologies using high‐resolution MRI and to examine subtype‐specific associations between high‐resolution MRI features and ischemic infarction.
Guangsong Han +8 more
wiley +1 more source
Management of patients with protein s deficiency: focus on clinical course and direct oral anticoagulants. [PDF]
Nicola A +14 more
europepmc +1 more source
Recurrent intracranial hemorrhage secondary to congenital factor XIII deficiency: A case report and literature review. [PDF]
Zichao X, Wei X, Hai Y, Jianyue W.
europepmc +1 more source
A Case of Factor XIII Deficiency Identified by Recurrent Postoperative Bleeding After Tonsillectomy. [PDF]
Teramura T +6 more
europepmc +1 more source
Acquired Coagulation Factor XIII Deficiency With Spontaneous Splenic Rupture: A Case Report. [PDF]
Lu J, Zhu X.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Seminars in Thrombosis and Hemostasis, 2009
Factor X (FX) deficiency is a rare, recessively inherited bleeding disorder representing 10% of all rare bleeding diseases and affecting 1 in every 1,000,000 people. Its clinical presentation places FX deficiency among the most severe of the rare coagulation defects, typically including hemarthroses, hematomas, and umbilical cord, gastrointestinal, and
Marzia, Menegatti, Flora, Peyvandi
openaire +3 more sources
Factor X (FX) deficiency is a rare, recessively inherited bleeding disorder representing 10% of all rare bleeding diseases and affecting 1 in every 1,000,000 people. Its clinical presentation places FX deficiency among the most severe of the rare coagulation defects, typically including hemarthroses, hematomas, and umbilical cord, gastrointestinal, and
Marzia, Menegatti, Flora, Peyvandi
openaire +3 more sources

